DOMNEXVI
Live / Allowed — Published for opposition (as of 13 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99682808
- Mark type
- Word mark
- Filed
- 04 Mar 2026
- Published for opposition
- 13 Oct 2026
- Attorney of record
- Cynthia Smuzynska
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of HIV infection; Pharmaceutical preparations for the treatment of viral infection, fungal infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, oncological diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders, endocrine diseases and disorders, and gastrointestinal diseases and disorders
Owner
- Gilead Sciences Ireland UC, Carrigtohill, Co. Cork, IE
- Gilead Sciences Ireland UC, Carrigtohill, Co. Cork, IE
Prosecution history
- 13 Oct 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Oct 2026 — PUBLISHED FOR OPPOSITION
- 07 Oct 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Sept 2026 — ASSIGNED TO LIE
- 10 Sept 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 25 Apr 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 25 Apr 2026 — LETTER OF SUSPENSION E-MAILED
- 25 Apr 2026 — SUSPENSION LETTER WRITTEN
- 25 Apr 2026 — EXAMINER'S AMENDMENT ENTERED
- 25 Apr 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Apr 2026 — EXAMINERS AMENDMENT E-MAILED
- 25 Apr 2026 — EXAMINERS AMENDMENT -WRITTEN